Abstract
Infection with neurotropic strains of mouse hepatitis virus (MHV) results in rapid leukocyte infiltration into the central nervous system (CNS). The inflammatory response controls virus replication but fails to mediate sterile clearance. The persistence of viral RNA and inflammatory cells within the CNS is associated with the development of ongoing demyelination. Matrix metalloproteinases (MMPs) are a family of proteases involved in degradation of the extracellular matrix (ECM). During inflammatory responses MMPs are thought to play a significant role in breaking down the basement membrane surrounding blood vessels as well as parenchymal ECM thereby facilitating leukocyte infiltration. MMPs have also been associated with activation of chemokines and perhaps more significantly the degradation of myelin proteins and generation of autoantigens. Recent examination of MMP expression during MHV infection suggests that MMP-3, -9 and -12 are involved in the inflammatory response. The proinflammatory effects of these MMPs are likely tempered by induction of tissue inhibiter of metalloproteinase-1 expression.
Chapter PDF
Similar content being viewed by others
Key words
References
Allport, J.R., Lim, Y.C., Shipley, J.M., Senior, R.M., Shapiro, S.D., Matsuyoshi, N., Vestweber, D., and Luscinskas, F.W. Neutrophils from MMP-9-or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J. Leukoc. Biol. 2002; 71:821.
Anthony, D. C, Ferguson, B., Matyzak, M.K., Miller, K.M., Esiri, M.M., and Perry, V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 1997; 23:406.
Asahi, M, Wang, X., Mori, T., Sumii, T., Jung, J.C., Moskowitz, M.A., Fini, M.E., and Lo, E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001; 21:7724.
Birkedal-Hansen, H., Moore, W. G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen B., DeCarlo, A., and Engler, J.A. Matrix Metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 1993; 4:197.
Bond, M., Fabunmi, R.P., Baker, A.H., and Newby, A.C. Synergistic upregulation of Metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kB. FEBS Lett. 1998; 435:29.
Bond, M., Baker, A.H., and Newby, A.C. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and-3 upregulation in rabbit dermal fibroblasts. Biochem. Biophys. Res. Commun. 1999; 264:561.
Brew, K., Dinakarpandian, D., and Nagase, H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta. 2000; 1477:267.
Chandler, S., Cossins, J., Lury, J., and Wells, G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 1996; 228:421.
Chandler S., Coates, R., Gearing, A., Lury, J., Wells, G., and Bone, E. Matrix metalloproteinases degrade myelin basic protein. Neurosci. Lett. 1995; 201:223.
Clements J.M., Cossins, J.A., Wells, G.M., Corkill, D.J., Helfrich, K., Wood, L.M., Pigott, R., Stabler, G., Ward, G.A., Gearing, A.J., and Miller, K.M. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J. Neuroimmunol. 1997; 74:85.
Cossins, J.A., Clements, J.M., Ford, J., Miller, K.M., Pigott, R., Vos, W., Van der Valk, P., and De Groot, C.J. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta. Neuropathol. 1997; 94:590.
Cross, A.K., and Woodroofe, M.N. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro. Glia 1999; 28:183.
Cuzner, M.L. and Opdenakker, G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 1999; 94:1.
Dubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den Oord, J., Sciot, R., Meinhardt, T., Hammerling, G., Opdenakker, G., and Arnold, B. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J. Clin. Invest. 1999; 104:1507.
Edwards, J.A., Denis, F., and Talbot, P.J. Activation of glial cells by human coronavirus OC43 infection. J. Neuroimmunol. 2000; 108:73.
Giannelli G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W.G., and Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 1997; 277:225.
Gijbels, K., Galardy, R.E., and Steinman, L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 1994; 94:2177.
Goetzl, E.J., Banda, M.J., and Leppert, D. Matrix metalloproteinases in immunity. J. Immunol. 1996; 156:1.
Gottschall, P.E. and Yu, X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 1995; 64:1513.
Hartung, H.P., and Kieseier, B.C. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J. Neuroimmunol. 2000; 107:140.
Hewson, A.K., Smith, T., Leonard, J.P., and Cuzner, M.L. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm. Res. 1995; 44:345.
Horton, W.E., Jr., Udo, I., Precht, P., Balakir, R., and Hasty, K. Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation. In Vitro Cell. Dev. Biol. Anim. 1998; 34:378.
Johansson, N., Ahonen, M., and Kahari, V.M. Matrix metalloproteinases in tumor invasion. Cell. Mol. Life. Sci. 2000; 57:5.
Kleiner, D.E. Jr and Stetler-Stevenson, W.G. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell. Biol. 1993; 5:891.
Konttinen, Y.T., Ainola, M., Valleala, H., Ma, J., Ida, H., Mandelin, J., Kinne, R.W., Santavirta, S., Sorsa, T., Lopez-Otin, C, and Takagi, M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum. Dis. 1999; 58:691.
Leco, K.J., Hayden, L.J., Sharma, R.R., Rocheleau, H., Greenberg, A.H., and Edwards, D.R. Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene. 1992; 117:209.
Lichtinghagen, R., Seifert, T., Kracke, A., Marckmann, S., Wurster, U., and Heidenreich, F. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J. Neuroimmunol. 1999; 99:19.
Liedtke, W., Cannella, B., Mazzaccaro, R.J., Clements, J.M., Miller, K.M., Wucherpfennig, K.W., Gearing, A.J., and Raine, C.S. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann. Neurol. 1998; 44:35.
Liu, Z., Shipley, J.M., Vu, T.H., Zhou, X., Diaz, L.A., Werb, Z., and Senior, R.M. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 1998; 188:475.
Ma, Z., Qin, H., and Benveniste, E.N. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J. Immunol. 2001; 167:5150.
Madtes, D.K., Elston, A.L., Kaback, L.A., and Clark, J.G. Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol. 2001; 24:599.
Maeda, A. and Sobel, R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1996; 55:300.
Marten, N.W., Stohlman, S.A., and Bergmann, C.C. MHV infection of the CNS: mechanisms of immune-mediated control. Viral. Immunol. 2001; 14:1.
Nagase, H. and Woessner, J. F., Jr. Matrix metalloproteinases. J. Biol. Chem. 1999; 274:21491.
Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., and Van Damme, J. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 2001; 69:851.
Opdenakker, G., Van den Steen, P.E., and Van Damme, J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001; 22:571.
Ozenci, V., Kouwenhoven, M., Teleshova, N., Pashenkov, M., Fredrikson, S., and Link, H. Multiple sclerosis: pro-and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta. J Neuroimmunol. 2000; 108:236.
Pagenstecher, A., Stalder, A.K., Kincaid, C.L., Shapiro, S.D., and Campbell, I.L. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 1998; 152:729.
Proost P., Van Damme, J., and Opdenakker, G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem, Biophys. Res. Commun. 1993; 192:1175.
Reis, C. and Petrides, P.E. cytokine regulation of Matrix Metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler. 1995; 376:345.
Rudolph-Owen, L.A., Hulboy, D.L., Wilson, C.L., Mudgett, J., and Matrisian, L.M. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology. 1997;138:4902.
Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler Stevenson, W.G., and Seiki, M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett. 1996; 385:238.
Stohlman, S.A., Bergmann, C.C., and Perlman, S. Mouse hepatitis virus. In Persistent Viral Infections, Vol. 26. p. 537. R. A. a. I. Chen, ed. John Wiley & Sons, 1999.
Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995; 270:5331.
Stuve, O., Dooley, N.P., Uhm, J.H., Antel, J.P., Francis, G.S., Williams, G., and Yong, V.W. Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol. 1996; 40:853.
Trojano, M., Avolio, C., Liuzzi, G.M., Ruggieri, M., Defazio, G., Liguori, M., Santacroce, M.P., Paolicelli, D., Giuliani, F., Riccio, P., and Livrea, P. Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. Neurology. 1999; 53:1402.
Uhm, J.H., Dooley, N.P., Oh, L.Y., and Yong, V.W. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia. 1998; 22:53.
Van den Steen, P.E., Proost, P., Wuyts, A., Van Damme, J., and Opdenakker, G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. 2000; 96:2673.
Vissers, M.C., Winterbourn, C.C. Gelatinase contributes to the degradation of glomerular basement membrane collagen by human neutrophils. Coll. Relat. Res. 1988; 8:113.
Yong, V.W., Krekoski, C.A., Forsyth, P.A., Bell, R., and Edwards, D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 1998; 21:75.
Zhou, J., Stohlman, S.A., Atkinson, R., Hinton, D.R., and Marten, N.W. Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection. J. Virol. 2002; 76:7374.
Zhou, J., Stohlman, S.A., Hinton, D.R., and Marten, N.W. Neutrophils modulate inflammation during viral induced encephalitis. In press.
Zhou, J., Stohlman, S.A., Marten, N.W., Hinton, D.R. Regulation of matrix metalloproteinase (MMP) and tissue inhibitor of matrix metalloproteinase (TIMP) genes during JHMV infection of the central nervous system. Adv. Exp. Med. Biol. 2001; 494:329.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Marten, N.W., Zhou, J. (2005). The Role of Metalloproteinases in Corona Virus Infection. In: Lavi, E., Constantinescu, C.S. (eds) Experimental Models of Multiple Sclerosis. Springer, Boston, MA. https://doi.org/10.1007/0-387-25518-4_48
Download citation
DOI: https://doi.org/10.1007/0-387-25518-4_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25517-0
Online ISBN: 978-0-387-25518-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)